BioBridgeXAll companies

Tango Therapeutics, Inc.

Pharmaceutical company · Boston, Massachusetts, United States · Nasdaq: TNGX

Tango Therapeutics, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2020. Its shares trade on Nasdaq under the ticker TNGX. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Tango Therapeutics at a glance

Typepharmaceutical company
HeadquartersBoston, Massachusetts, United States
Earliest incorporation on record2020
Stock listingNasdaq: TNGX
SEC industryPharmaceutical Preparations
SEC CIK1819133

What does Tango Therapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $15 million sold (2025).

Frequently asked questions about Tango Therapeutics

Where is Tango Therapeutics headquartered?

Tango Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.

What does Tango Therapeutics do?

Tango Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Tango Therapeutics a public company?

Yes. Tango Therapeutics, Inc. trades on Nasdaq under the ticker TNGX.

When was Tango Therapeutics founded?

The earliest incorporation on record for Tango Therapeutics, Inc. is in 2020, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.